Pulling SEC filings + quote and writing the call…

Ulta Beauty, Inc.
Next earnings Aug 26, 2026 · consensus $6.26 EPS, $3.04B rev
Last earnings -1.2% on 2026-06-02
Best-in-class beauty retailer at a cheap 17.8x with 41% ROE; margin slippage is the offset, valuation does the work.
Revenue (FY2026) $12.4B · FY2026
The fundamentals carry the rating, but the price is rich (~22% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.
Ulta Beauty is a dominant US beauty specialty retailer (1,591 stores as of January 31, 2026) trading at a notably undemanding valuation. At $456.13 the stock is just 17.8x FY diluted EPS of $25.64 and 1.6x sales — cheap for a business earning a 41.1% return on equity. FY2026 revenue grew 9.7% to $12.4B, extending a multi-year growth record (from $8.63B in FY2022), and gross profit rose 10.4% to $4.85B with a healthy 39.1% gross margin.
The blemish is profitability: net income fell 4.0% to $1.15B and operating income slipped 2.0% to $1.53B, so operating margin (12.4%) and net margin (9.3%) are off prior peaks even as the top line grew. Diluted EPS still rose 1.2% to $25.64, helped by a 3.5% reduction in the share count via $901M of buybacks — capital discipline that supports per-share value even when net income dips. Operating cash flow grew 12.3% to $1.50B, comfortably funding both buybacks and $435M of capex (up 16.1%) for store growth and the international Space NK footprint.
Is ULTA a buy? The one-page verdict, explained →
BUY verdict with defined risk: the short call finances part of the long one; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $8.63B | $10.2B | $11.2B | $11.3B | $12.4B |
| Gross profit | $3.37B | $4.04B | $4.38B | $4.39B | $4.85B |
| Operating income | $1.30B | $1.64B | $1.68B | $1.56B | $1.53B |
| Net income | $986M | $1.24B | $1.29B | $1.20B | $1.15B |
| Diluted EPS | $17.98 | $24.01 | $26.03 | $25.34 | $25.64 |
| Net margin | 11.4% | 12.2% | 11.5% | 10.6% | 9.3% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001403568, latest 10-Q filed 2026-06-02) · EODHD · Proprietary analysis · as of 6/21/2026, 8:42:05 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:42 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-15 | MRKONIC GEORGE R JR Director | Sell | 383.00 @ $475.84 | $182K |
| 2026-06-10 | Smith Mike C. Director | Award | 404.00 | |
| 2026-06-10 | Nagler Lorna Director | Award | 404.00 | |
| 2026-06-10 | MRKONIC GEORGE R JR Director | Award | 404.00 | |
| 2026-06-10 | Landry Stephenie Lee Director | Award | 404.00 | |
| 2026-06-10 | Halligan Catherine Ann Director | Award | 404.00 |
| D. E. Shaw & Co. | 146K sh | $76.3M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1 buy · 1 sell · 2 members · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.